The present invention relates to a heteroarylpyrimidinone derivative represented by formula (I), a method for preparation thereof, and a use thereof as a therapeutic agent, in particular a use as an acetyl-CoA carboxylase (ACC) inhibitor, the definitions of the substituents in formula (I) being the same as the definitions in the description.